Trust Magazine

Tainted Dietary Supplements Put Consumers at Risk

Undeclared and unapproved pharmaceutical ingredients raise questions about oversight

In this Issue:

  • Spring 2019
  • Who is Generation Z
  • How Ohio Brought Fairness to Payday Loans
  • When the Sea Runs Dry: One Fishing Community's Story
  • Knowledge Borne of Challenging Times
  • A New Perspective on Mangroves
  • Noteworthy
  • Western Australia Commits to Historic National Parks Expansion
  • How the Census Will Reach the New Urban Millennials
  • Prison, Probation, and Parole Reforms: the Texas Model
  • Two Indigenous Cultures Bond Over a Shared Approach to Conservation
  • Tainted Dietary Supplements Put Consumers at Risk
  • When It Comes to Conserving Canada’s Boreal Forest, Caribou Are Key
  • Pew-Templeton Project Seeks Answers About Faith
  • Progress on State Public Pension Reforms
  • Return on Investment
  • Improving Public Policy
  • Informing the Public
  • Invigorating Civic Life
  • Americans Still Like Their News on TV
  • View All Other Issues
Tainted Dietary Supplements Put Consumers at Risk

Hundreds of products containing potentially harmful pharmaceutical ingredients are being marketed to consumers as dietary supplements, a study published in October found, raising questions about the Food and Drug Administration’s ability to remove these tainted products from the market.

Dietary supplements cannot legally contain pharmaceutical ingredients. But a study published in the Journal of the American Medical Association found that more than 700 dietary supplements sold from 2007 to 2016 included pharmaceutical ingredients that had been the subject of FDA warnings. Some of the pharmaceuticals were components of FDA-approved prescription drugs, while others were drug ingredients that had been withdrawn from the market or that FDA had never approved. According to the study’s authors, the undeclared drugs represent “an important public health concern.”

A separate study published in December in JAMA Internal Medicine found that several brands of supplements on the market contain at least one of four prohibited stimulants, even though FDA had sent warning letters to their manufacturers and issued public notices about the ingredients. One notice cautioned that supplements containing a stimulant called dimethylamylamine can elevate blood pressure and could lead to cardiovascular problems. It noted that FDA had received 86 reports of illnesses or deaths associated with supplements containing it.

Most American adults take at least one dietary supplement a day, including products such as vitamins, minerals, herbs or other botanicals, amino acids (the building blocks of proteins), or other dietary ingredients. The number of these products on the market has grown from about 4,000 in 1994 to about 80,000 today. The new studies raise serious questions about whether FDA can take effective action when problems with supplements arise.

Although FDA can mandate recalls of dietary supplements, this authority does not extend to drugs (with the exception of certain controlled substances), calling into question the agency’s ability to require a company to recall products marketed as supplements that contain drug ingredients. And unlike the oversight of drugs, the agency has no mechanism to know what dietary supplement manufacturers are producing.

To more efficiently monitor the marketplace and take quick action if needed, FDA should have access to more information about the dietary supplement marketplace, such as the names of specific products, their ingredients, and product labels, as well as the names and contact information for companies selling them. Former FDA Commissioner Scott Gottlieb recently made a similar point, writing that if supplement manufacturers were required to submit information about their products to the agency, it would improve transparency, promote risk-based regulation, facilitate efficient enforcement of the law, and establish new ways to identify dangerous products. Giving FDA more information and clarifying the agency’s recall authority for supplements tainted with pharmaceutical ingredients would better protect Americans.

Sandra Eskin is a director with The Pew Charitable Trusts’ work on food safety, and Elizabeth Jungman is a director with Pew’s work on public health.

This article was previously published on and appears in this issue of Trust Magazine.

When It Comes to Conserving Canada’s Boreal Forest, Caribou Are Key Two Indigenous Cultures Bond Over a Shared Approach to Conservation

National Homeownership Month


37 Researchers Working to Transform Biomedical Science

Quick View

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.


FDA Needs Tools to Monitor Dietary Supplement Safety

Quick View

At a time when most Americans say they have taken dietary supplements, the Food and Drug Administration just does not have the tools to effectively ensure that these products are safe. In a recent survey, a majority of adults echoed this concern: 7 in 10 said they think the agency cannot protect consumers from harmful supplements.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.